Mr. Potti is a seasoned pharmaceutical executive and entrepreneur with over 35 years of experience. His areas of expertise include finance, accounting, tax, supply chain, and product strategy. Mr. Potti began his career as the controller of Duramed Pharmaceuticals in Long Island, New York. He was the founder and Chief Operating Officer of Cadista Pharmaceuticals, now a division of Jubilant Life Sciences of India.
Mr. Potti served, most recently as the executive vice president of Epic Pharmaceuticals, where he led the sale process of the company to Humanwell Healthcare of China.
Mr. Potti is active in biotech and specialty pharma venture capital. He was an initial investor and board member of InnoPharma, which was later acquired by Pfizer.
Mr. Potti received BS. in Chemistry from the University of Kerala, India and is a CPA.